Bulletin
Investor Alert

Alkermes PLC

NAS: ALKS

GO
/marketstate/country/us

After Hours

/zigman2/quotes/205084517/composite

$

29.71

Change

0.00 0.00%

Volume

Volume 85,767

Jun 24, 2022, 5:00 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/205084517/composite

Today's close

$ 29.56

$ 29.71

Change

+0.15 +0.51%

Day low

Day high

$29.39

$30.21

Open
Open: 29.69

52 week low

52 week high

$21.24

$33.00

Open

Market cap

$4.83B

Average volume

1.69M

P/E ratio

N/A

Rev. per Employee

$543,133

EPS

-0.38

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/alks

MarketWatch News on ALKS

  1. How to Avoid the Biotech Bear Market: Get Some Products Approved

    9:33 p.m. May 13, 2022

    - Barron's Online

  2. Nektar Shares Halve on Cancer Trial Failure

    6:14 p.m. March 14, 2022

    - Barron's Online

  3. Alkermes downgraded to underperform from neutral at BofA Securities

    9:41 a.m. Sept. 2, 2021

    - Tomi Kilgore

  4. Alkermes stock halted for news pending

    7:00 a.m. June 1, 2021

    - Tomi Kilgore

  5. Biotech Is Down. How It Could Come Back.

    9:41 a.m. May 17, 2021

    - Barron's Online

  6. The Case for AbbVie as a Top Biopharma Stock in 2021

    9:45 a.m. Jan. 7, 2021

    - Barron's Online

  7. Alkermes upgraded to buy from neutral at Mizuho

    6:35 a.m. Oct. 15, 2020

    - Tomi Kilgore

  8. Alkermes stock price target raised to $24 from $19 at Mizuho

    6:04 a.m. Oct. 15, 2020

    - Tomi Kilgore

  9. Alkermes downgraded to neutral from buy at BofA Securities

    11:40 a.m. Feb. 14, 2020

    - Tomi Kilgore

  10. Alkermes stock price target cut to $20 from $31 at BofA Securities

    11:40 a.m. Feb. 14, 2020

    - Tomi Kilgore

  11. Alkermes downgraded to neutral from overweight at J.P. Morgan

    8:51 a.m. Feb. 14, 2020

    - Tomi Kilgore

  12. Alkermes stock price target cut to $21 from $25 at J.P. Morgan

    8:52 a.m. Feb. 14, 2020

    - Tomi Kilgore

  13. FDA told Alkermes to stop publishing Vivitrol ad

    1:12 p.m. Dec. 11, 2019

    - Jaimy Lee

  14. Alkermes to acquire Rodin Therapeutics for up to $950 million

    8:30 a.m. Nov. 18, 2019

    - Ciara Linnane

  15. Biogen shares fall 3%

    4:08 p.m. Nov. 14, 2019

    - Jaimy Lee

  16. Biogen, Alkermes MS treatment Vumerity gets FDA approval

    7:33 a.m. Oct. 30, 2019

    - Tomi Kilgore

  17. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/alks

Other News on ALKS

  1. Gilead (GILD) Announces Positive Data on Hepcludex for HDV

    12:30 p.m. Today

    - Zacks.com

  2. Walgreens (WBA) to Report Q3 Earnings: What's in the Cards?

    12:01 p.m. Today

    - Zacks.com

  3. F-star (FSTX) Stock Rises on Buyout Offer From Sino Biopharm

    10:08 a.m. Today

    - Zacks.com

  4. Sarepta (SRPT) Down on Clinical Hold on DMD Candidate SRP-5051

    9:45 a.m. Today

    - Zacks.com

  5. Tandem Diabetes (TNDM) Global Pump Sales Aid, Price Issue Ails

    9:31 a.m. Today

    - Zacks.com

  6. Here's Why You Should Retain Neogen (NEOG) Stock for Now

    11:21 a.m. June 23, 2022

    - Zacks.com

  7. Merck's (MRK) Pneumococcal Vaccine Gets FDA Nod for Kids

    8:39 a.m. June 23, 2022

    - Zacks.com

  8. J&J's (JNJ) Stock Outperforms Industry YTD: Here's Why

    9:23 a.m. June 22, 2022

    - Zacks.com

  9. Here's Why You Should Retain National Vision (EYE) For Now

    12:14 p.m. June 21, 2022

    - Zacks.com

  10. Loading more headlines...
/news/pressrelease/company/us/alks

Press Releases on ALKS

  1. Alkermes to Participate in the Goldman Sachs Healthcare Conference

    4:00 p.m. June 8, 2022

    - PR Newswire - PRF

  2. Alkermes to Participate in the Jefferies Healthcare Conference

    4:00 p.m. June 1, 2022

    - PR Newswire - PRF

  3. Sarissa Condemns Poor Corporate Governance at Alkermes

    9:43 a.m. May 27, 2022

    - BusinessWire - BZX

  4. Alkermes to Report First Quarter Financial Results on April 27, 2022

    4:00 p.m. April 20, 2022

    - PR Newswire - PRF

  5. Alkermes to Participate in the Stifel 2022 CNS Days

    4:00 p.m. March 22, 2022

    - PR Newswire - PRF

  6. Loading more headlines...

Rates »

Link to MarketWatch's Slice.